Revenue
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 · Dec 31 | 2020 · Dec 2 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $299,061 | $0 | — | — | — | — | — | — |
| Research & development | $322,225 | $1.6M | $2.0M | $6.3M | $4.3M | $3.1M | — | $5.7M |
| Operating expenses | $9.3M | $6.8M | $8.3M | $16.1M | $12.6M | $11.2M | — | $15.5M |
| Operating income | −$9.0M | −$6.8M | — | — | — | — | — | — |
| EBITDAderived | −$9.0M | −$6.8M | — | — | — | — | — | — |
| Net income | −$28.7M | −$12.8M | −$6.0M | −$5.6M | −$12.6M | −$12.7M | −$11.2M | −$15.1M |
| Basic EPSper diluted share | -$8.81 | -$10.99 | $29.56 | -$0.81 | $2.51 | $12.03 | — | $3.01 |
| Diluted EPSper diluted share | -$8.81 | -$10.99 | $29.56 | -$0.81 | $2.51 | $12.03 | — | $3.01 |